The Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026 aims to boost U.S. bioindustrial manufacturing capacity.
The Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026 seeks to enhance U.S. bioindustrial manufacturing capabilities by establishing technology maturation facilities. These facilities will focus on research, development, and commercial application of biotechnology-based products. The bill emphasizes the need for a network of these facilities to maximize production variety and complement existing infrastructure. It also highlights the importance of workforce development and collaboration with various stakeholders, including industry, academia, and federal agencies.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.